| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2008 | AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia | Koeberl, D. D.; Pinto, C.; Sun, B.; Kozink, D. M.; Benjamin, D. K.; Demaster, A. K.; Kruse, M. A.; Vaughn, V.; Hillman, S.; Bird, A.; Jackson, M.; Brown, T.; Kishnani, P. S.; Chen, Y. T. | Mol Ther 16, 665-672 | | | |
| 2006 | Ambulatory electrocardiogram analysis in infants treated with recombinant human acid alpha-glucosidase enzyme replacement therapy for Pompe disease | Cook, A. L.; Kishnani, P. S.; Carboni, M. P.; Kanter, R. J.; Chen, Y. T.; Ansong, A. K.; Kravitz, R. M.; Rice, H.; Li, J. S. | Genet Med 8, 313-317 | | | |
| 2001 | Canine model and genomic structural organization of glycogen storage disease type Ia (GSD Ia) | Kishnani, P. S.; Faulkner, E.; VanCamp, S.; Jackson, M.; Brown, T.; Boney, A.; Koeberl, D.; Chen, Y. T. | Vet Pathol 38, 83-91 | | | |
| 2006 | Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease | Kishnani, P. S.; Nicolino, M.; Voit, T.; Rogers, R. C.; Tsai, A. C.; Waterson, J.; Herman, G. E.; Amalfitano, A.; Thurberg, B. L.; Richards, S.; Davison, M.; Corzo, D.; Chen, Y. T. | J Pediatr 149(1), 89-97 | | | |
| 2006 | Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid alpha-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease | Zhang, H.; Kallwass, H.; Young, S. P.; Carr, C.; Dai, J.; Kishnani, P. S.; Millington, D. S.; Keutzer, J.; Chen, Y. T.; Bali, D. | Genet Med 8, 302-306 | | | |
| 1999 | Dubowitz syndrome: a defect in the cholesterol biosynthetic pathway? | Ahmad, A.; Amalfitano, A.; Chen, Y. T.; Kishnani, P. S.; Miller, C.; Kelley, R. | Am J Med Genet 86, 503-504 | | | |
| 2006 | Electrocardiographic response to enzyme replacement therapy for Pompe disease | Ansong, A. K.; Li, J. S.; Nozik-Grayck, E.; Kravitz, R. M.; Idriss, S. F.; Kanter, R. J.; Rice, H.; Chen, Y. T.; Kishnani, P. S. | Genet Med 8, 297-301 | | | |
| 2007 | Enhanced response to enzyme replacement therapy in Pompe disease after the indcution of immune tolerance | Sun, B.; Bird, A.; Young, S. P.; Kishnani, P. S.; Chen, Y. T.; Koeberl, D. D. | Am J Hum Genet 81, 1042-1049 | | | |
| 2007 | Fractures in children with Pompe disease: a potentiallong-term complication | Case, L. E.; Hanna, R.; Frush, D. P.; Krishnamurthy, V.; DeArmey, S.; Mackey, J.; Boney, A.; Morgan, C.; Corzo, D.; Bouchard, S.; Weber, T. J.; Chen, Y. T.; Kishnani, P. S. | Pediatr Radiol 37(5), 437-445 | | | |
| 2000 | Genotype-phenotype correlation in two frequent mutations and mutation update in type III glycogen storage disease | Shaiu, W. L.; Kishnani, P. S.; Shen, J.; Liu, H. M.; Chen, Y. T. | Mol Genet Metab 69, 16-23 | | | |
| 2005 | Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease | An, Y.; Young, S. P.; Kishnani, P. S.; Millington, D. S.; Amalfitano, A.; Corz, D.; Chen, Y. T. | Mol Genet Metab 85, 247-254 | | | |
| 2007 | Glycogen storage disease type III-hepatocellular carcinoma a long-term complication? | Demo, E.; Frush, D.; Gottfried, M.; Koepke, J.; Boney, A.; Bali, D.; Chen, Y. T.; Kishnani, P. S. | Journal of Hepatology 46(3), 492-498 | | | |
| 2007 | Important role of abnormal glycogen structure in the development of liver cirrhosis and progression to hepatocellular carcinoma in patients with glycogen storage disease type-III | Kishnani, P. S.; Chen, Y. T. | J Hepatology 47(2), 300-301 | | | |
| 1997 | Isolation and nucleotide sequence of canine glucose-6-phosphatase mRNA: identification of mutation in puppies with glycogen storage disease type Ia | Kishnani, P. S.; Bao, Y.; Wu, J. Y.; Brix, A. E.; Lin, J. L.; Chen, Y. T. | Biochem Mol Med 61, 168-177 | | | |
| 1999 | Nutritional deficiencies in a patient with glycogen storage disease type Ib | Kishnani, P. S.; Boney, A.; Chen, Y. T. | J Inherit Metab Dis 22, 795-801 | | | |
| 1996 | Pulmonary hypertension in glycogen storage disease type I | Kishnani, P. S.; Bengur, A. R.; Chen, Y. T. | J Inherit Metab Dis 19, 213-216 | | | |
| 2003 | Rare disorders of metabolism with elevated butyryl- and isobutyryl-carnitine detected by tandem mass spectrometry newborn screening | Koeberl, D. D.; Young, S. P.; Gregersen, N. S.; Vockley, J.; Smith, W. E.; Benjamin, D. K.; An, Y.; Weavil, S. D.; Chaing, S. H.; Bali, D.; McDonald, M. T.; Kishnani, P. S.; Chen, Y. T.; Millington, D. S. | Pediatr Res 54, 219-223 | | | |
| 2007 | Recombinant human acid alpha-glucosidase. Major clinical benefits in infantile-onset Pompe disease | Kishnani, P. S.; Corzo, D.; Nicolino, M.; Byrne, B.; Mandel, H.; Hwu, W. L.; Leslie, N.; Levine, J.; Spencer, C.; McDonald, M.; Li, J.; Dumontier, J.; Halberthal, M.; Chien, Y. H.; Hopkin, R.; Vijayaraghavan, S.; Gruskin, D.; Bartholomew, D.; van der Ploeg, A.; Clancy, J. P.; Parini, R.; Morin, G.; Beck, M.; De la Gastine, G. S.; Jokic, M.; Thurberg, B.; Richards, S.; Bali, D.; Davison, M.; Worden, M. A.; Chen, Y. T.; Wraith, J. E. | Neurology 68(2), 99-109 | | | |
| 2007 | Sibling phenotype concordance in classical infantile Pompe disease | Smith, W. E.; Sullivan-Saarela, J. A.; Li, J. S.; Cox, G. F.; Corzo, D.; Chen, Y. T.; Kishnani, P. S. | Am J Med Genet A 143A(21), 2493-501 | | | |
| 2011 | The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: lessons learned from infantile Pompe disease. | Banugaria, S. G.; Prater, S. N.; Ng, Y. K.; Kobori, J. A.; Finkel, R. S.; Ladda, R. L.; Chen, Y. T.; Rosenberg, A. S.; Kishnani, P. S. | Genetics in Medicine 13(8), 729-736 | | | |
